↓ Skip to main content

Pharmacogenetics of Efficacy and Safety of HCV Treatment in HCV-HIV Coinfected Patients: Significant Associations with IL28B and SOCS3 Gene Variants

Overview of attention for article published in PLOS ONE, November 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
facebook
2 Facebook pages
f1000
1 research highlight platform

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
82 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pharmacogenetics of Efficacy and Safety of HCV Treatment in HCV-HIV Coinfected Patients: Significant Associations with IL28B and SOCS3 Gene Variants
Published in
PLOS ONE, November 2012
DOI 10.1371/journal.pone.0047725
Pubmed ID
Authors

Francesc Vidal, Miguel López-Dupla, Montserrat Laguno, Sergi Veloso, Josep Mallolas, Javier Murillas, Carmen Cifuentes, Lluis Gallart, Teresa Auguet, Gloria Sampériz, Antoni Payeras, Pilar Hernandez, Mireia Arnedo, Josep Ma Gatell, Cristóbal Richart

Abstract

This was a safety and efficacy pharmacogenetic study of a previously performed randomized trial which compared the effectiveness of treatment of hepatitis C virus infection with pegylated interferon alpha (pegIFNα) 2a vs. 2b, both with ribavirin, for 48 weeks, in HCV-HIV coinfected patients.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 82 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 4%
United Kingdom 2 2%
Brazil 1 1%
Spain 1 1%
Colombia 1 1%
Unknown 74 90%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 16 20%
Student > Master 13 16%
Researcher 11 13%
Student > Bachelor 9 11%
Student > Postgraduate 6 7%
Other 17 21%
Unknown 10 12%
Readers by discipline Count As %
Medicine and Dentistry 27 33%
Agricultural and Biological Sciences 15 18%
Psychology 8 10%
Pharmacology, Toxicology and Pharmaceutical Science 6 7%
Biochemistry, Genetics and Molecular Biology 5 6%
Other 7 9%
Unknown 14 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2012.
All research outputs
#13,370,975
of 22,684,168 outputs
Outputs from PLOS ONE
#106,501
of 193,651 outputs
Outputs of similar age
#100,576
of 184,200 outputs
Outputs of similar age from PLOS ONE
#2,369
of 4,916 outputs
Altmetric has tracked 22,684,168 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 193,651 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.0. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 184,200 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4,916 others from the same source and published within six weeks on either side of this one. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.